Type 2 & other diabetes

Association between diabetes mellitus and primary restenosis following endovascular treatment: a comprehensive meta-analysis of randomized controlled trials

Cardiovasc DiabetolPublished Systematic review and meta-analysis of randomised trials

Pooled result · Primary restenosis after endovascular treatmentResult — go to the resultRelative risk 1.43 95% CI 1.25–1.62

Authors' conclusion

This meta-analysis of all currently available RCTs showed that patients with DM are more prone to primary restenosis after endovascular treatment.

Study context

Population
Patients undergoing endovascular treatment (percutaneous transluminal angioplasty (PTA) or stenting) of coronary or femoral popliteal artery lesions; RCTs searched in PubMed/Medline, EMBASE and Cochrane Library, 01/1990 to 12/2022
Participants
31,066 patients20 RCTs
Comparison
Diabetes mellitus (DM) vs no DM
Outcome
Restenosis: >50% stenosis at angiography, or TLR of the primary operation lesion
Follow-up
During the
Methodological detailsrandom effects models, Grading of Recommendations Assessment, Development and Evaluation (GRADE)
  • Random effects models
  • GRADE

Pooled result

Primary restenosis after endovascular treatment

Relative risk

1.43

95% CI 1.25–1.62

P = 0.001

DMvs Without DM
RR 1.43 (95% CI 1.25–1.62); P = 0.001

As reported in the abstract

Original publication

Association between diabetes mellitus and primary restenosis following endovascular treatment: a comprehensive meta-analysis of randomized controlled trials. Cardiovasc Diabetol. Published 22 April 2024. doi:10.1186/s12933-024-02201-6

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.